retatrutide description Buy in the UK What is Retatrutide Research Peptide

GLP-1 only

Why does retatrutide need medical supervision

The SOUL trial (NCT06659718) will investigate the effect of semaglutide on cardiovascular outcomes in patients with T2DM who have preexisting cardiovascular disease and/or CKD

Dosing and protocols are determined by the prescriber

Challenges Hindering GLP-1 Nutritional Support Growth Despite the growing demand, the industry faces challenges related to gastrointestinal side effects, which affect up to 50% of GLP-1 users

At 24 weeks, liver fat reduction was: 1 mg : 42.9% 4 mg : 57.0% 8 mg : 81.4% 12 mg : 82.4% Placebo : +0.3% These findings highlight retatrutides versatility across various research applications, from metabolic studies to liver health investigations